Post Subject #573   0 Hello Dew, do you know what is the lgonber 04/11/18 06:20:48 AM #572   0 Nice buy, I never got anymore. just-for-fun 02/26/18 11:51:08 AM #571   0 Same here. Conference call sounded positive too. I D_A 02/23/18 09:48:44 AM #570   0 I thought the quarter and year were good, just-for-fun 02/22/18 07:14:28 PM #569   0 EXAS -9% on Taiwanese liquid-biopsy test profiled by DewDiligence 01/17/18 10:37:44 AM #568   0 *****Very good article IMHO. TREND1 11/21/17 11:37:14 AM #567   0 ***** Cologuard has no competition at this time. TREND1 11/16/17 02:11:57 PM #566   0 Nov 16, 2017 video on cologuard TREND1 11/16/17 01:37:34 PM #565   0 My GI is mailing me a Cologuard® after TREND1 11/16/17 12:52:03 PM #564   0 EXAS 30 MIN DAY WEEK TREND1 11/16/17 12:48:43 PM #563   0 Cologuard® revenue increased 158 percent to $73 million TREND1 11/16/17 12:15:09 PM #562   0 NET LOSS FOR Q3 = -27 M TREND1 11/14/17 01:25:53 PM #561   0 The Exact Sciences team delivered another strong quarter TREND1 11/14/17 01:03:29 PM #560   0 EXAS 30 MIN TREND DOWN TREND1 11/14/17 12:42:59 PM #559   0 EXAS DAY TREND1 11/14/17 12:30:46 PM #558   0 Earnings Per Share (EPS)= -1.63 TREND1 11/14/17 12:24:06 PM #557   0 Float = 108.69M TREND1 11/14/17 12:23:18 PM #556   0 Profit/Loss = $ -167.21M TREND1 11/14/17 12:22:30 PM #555   0 EXAS WEEKLY 9 YEARS TREND1 11/14/17 12:20:20 PM #554   0 Hey DewDiligence! maxxam 11/12/17 06:56:34 AM #553   0 bfost, I think we are getting closer to ranjo 11/05/17 07:02:32 PM #552   0 My favorite biotechs now are RVNC and ENTA. DewDiligence 11/04/17 04:48:14 PM #551   0 Hey Dew (Biko), can you please share about maxxam 11/04/17 09:11:07 AM #550   0 yup UPOD - beat and raise. bfost 10/31/17 12:55:07 PM #549   0 EXAS always lowballs the quarterly guidance. DewDiligence 10/31/17 11:58:19 AM #548   0 I'm a bit surprised by the strength of bfost 10/31/17 11:53:59 AM #547   0 EXAS +8%/AH/to-ATH on 3Q17 results: DewDiligence 10/30/17 04:32:33 PM #546   0 Management has refused to say when they expect DewDiligence 10/22/17 06:41:26 PM #545   0 What percentage of market does EXAS need to r clarke 10/22/17 06:26:31 PM #544   0 I have it figured in the same neighborhood, IronPantz 10/01/17 06:19:04 PM #543   0 I have this at 3.3 million test annually ranjo 09/27/17 04:43:23 PM #542   0 Poop in a can is gold in my IronPantz 09/23/17 10:34:27 PM #541   0 2% of the screening market should be able ranjo 07/26/17 09:04:23 PM #540   0 EXAS buy 41.9068 stocktrademan 07/26/17 10:24:52 AM #539   0 EXAS +8%/AH on 2Q17 results (135K tests) and DewDiligence 07/25/17 04:35:49 PM #538   0 EXAS sells 8.05M* shares @$35.00—a 6% discount to DewDiligence 06/07/17 07:58:14 AM #537   0 insiders sold in the 17's now in the ranjo 05/31/17 06:20:12 PM #536   0 EXAS buy 32.42 stocktrademan 05/24/17 12:39:28 PM #535   0 EXAS will be trading in the high 30S, Thirdeyeblind 05/22/17 11:13:34 AM #534   0 EXAS -4% on bear piece by Citron Research: DewDiligence 05/15/17 11:00:19 AM #533   0 pank, I was being a smart arse ... ranjo 05/04/17 11:26:32 PM #532   0 Insiders keep getting lots of shares continuously, so pankajanc 04/29/17 04:22:38 AM #531   0 insiders sold in the 17's now in the ranjo 04/27/17 11:37:11 PM #530   0 EXAS—(+27%)—raised 2017 guidance big-league: DewDiligence 04/27/17 05:07:52 PM #529   0 exas has one product only.they need to diversify tom46 04/26/17 01:33:05 PM #528   0 Ranjo - "more CG" bfost 04/24/17 04:34:02 PM #527   0 Ranjo - I assume you are happy with bfost 04/23/17 11:11:52 PM #526   0 now at 24 wth ??? ranjo 04/20/17 12:36:02 AM #525   0 PoC data on lung-nodule test at AACR: #msg-129129480. DewDiligence 03/01/17 07:25:40 PM #524   0 EXAS +13% on 4Q16 results/2017 guidance: #msg-128884019. DewDiligence 02/21/17 05:48:36 PM Post Subject

© 2018 InvestorsHub.com, Inc.